Magnesium supplementation is widely utilized across both clinical and consumer settings, yet the formulation used can meaningfully influence absorption, gastrointestinal tolerability, and long-term adherence. While elemental magnesium content is often emphasized on supplement bottles (i.e., 100 mg versus 300 mg), differences in solubility and bioavailability between magnesium forms may substantially affect how much magnesium is ultimately absorbed and tolerated in practice. These considerations are particularly relevant for individuals using magnesium as part of a daily or long-term supplementation regimen.
Magnesium oxide remains a widely used form of magnesium because of its high elemental magnesium content, while magnesium glycinate chelate is often valued for its superior absorption and gastrointestinal tolerability. One formulation that has become increasingly popular in clinical nutrition is magnesium glycinate chelate buffered (also known as magnesium bisglycinate chelate buffered). This buffered, chelated form combines these two types of magnesium: magnesium glycinate chelate with magnesium oxide. This approach is designed to support elemental magnesium delivery while also promoting absorption and digestive tolerability, making it relevant for both the general population and individuals with impaired digestion or absorption.
Clinical Importance of Magnesium
Suboptimal magnesium status remains relatively common across many adult populations. It may result from several factors, including low dietary intake, gastrointestinal dysfunction, chronic stress, alcohol use, medication exposure, and increased physiological demand. Modern-day diets often consist of highly processed foods and a limited intake of magnesium-rich foods such as legumes, leafy greens, nuts, and seeds, which may further contribute to inadequate intake. These considerations are clinically relevant given magnesium’s involvement in more than 600 enzymatic reactions related to ATP-dependent energy production, neuromuscular signaling, glycemic regulation, cardiovascular physiology, electrolyte balance, and bone metabolism, among others. Because magnesium participates in such a broad range of processes within the body, suboptimal magnesium status has the potential to influence multiple physiologic systems.
Understanding Magnesium Glycinate Chelate Buffered
Magnesium glycinate chelate buffered utilizes a buffered chelate system to support elemental magnesium delivery while still preserving many of the bioavailability and gastrointestinal advantages associated with chelated forms. During chelation, magnesium is bound to two molecules of the amino acid glycine, forming a stable ring-like structure that helps protect and stabilize the mineral during digestion while facilitating its uptake into the intestinal cells. This chelated structure may help support magnesium uptake while reducing occasional loose stools associated with less absorbable magnesium forms. Occasional loose stools may occur with certain magnesium supplements due to greater amounts of unabsorbed magnesium remaining in the intestinal lumen, thereby increasing osmotic activity in the gastrointestinal tract.
Chelation may also help minimize interactions between magnesium and dietary compounds such as phytates, which are known to impair mineral absorption and bioavailability. Because chelated forms are generally absorbed more efficiently and produce less osmotic activity within the gastrointestinal tract, they are often better tolerated than formulas using only magnesium oxide, particularly during long-term use.
The “buffered” component of this form refers to the inclusion of magnesium oxide alongside the chelated glycinate portion. Rather than using magnesium oxide as the primary source of magnesium, this approach incorporates it strategically to increase elemental magnesium content while still preserving many of the absorption and tolerability advantages of chelated forms. This allows the formula to support magnesium delivery while limiting some of the gastrointestinal drawbacks commonly associated with magnesium formulations with lower bioavailability.
Evidence on Absorption and Tolerability
Recent data comparing magnesium glycinate chelate buffered with magnesium oxide alone indicate meaningful differences in absorption. In vitro studies have shown this form to be approximately four times more absorbable than magnesium oxide alone. In an unpublished crossover study (150 mg elemental Mg; n = 14), the magnesium glycinate chelate buffered form produced 37% greater serum magnesium exposure over eight hours (AUC) compared with magnesium glycinate chelate alone (0.225 vs. 0.164). Recent human studies have supported these findings, suggesting improved magnesium uptake relative to conventional magnesium oxide. While these findings should be considered alongside differences in study design and dosing, they are consistent with other research showing organic and chelated magnesium forms tend to have higher bioavailability than inorganic salts such as magnesium oxide alone.
Gastrointestinal tolerability is another clinically meaningful consideration, as loose stools and abdominal discomfort are commonly reported with supplements that only contain magnesium oxide. Glycinate forms also tend to produce fewer gastrointestinal side effects, likely because of their greater absorption and reduced osmotic load in the lower gastrointestinal tract. In a randomized, placebo-controlled trial of 80 adults reporting poor sleep, participants who took 250 mg/day of magnesium bisglycinate for 28 days reported no gastrointestinal discomfort or serious adverse effects. Although individual responses to any supplement can vary, these findings support the tolerability of glycinate-based formulations during sustained daily use and help explain why magnesium glycinate chelate buffered may be a more suitable option for long-term supplementation.
Clinical Considerations
The clinical effectiveness of a magnesium supplement depends on more than elemental magnesium content alone. Differences in solubility, bioavailability, and gastrointestinal response can meaningfully influence both efficacy and long-term adherence. Magnesium glycinate chelate buffered represents one approach to addressing these challenges by combining chelated magnesium glycinate with a smaller proportion of magnesium oxide to support magnesium delivery while preserving many of the advantages associated with chelated forms. For individuals seeking a magnesium formulation suitable for broader use, magnesium glycinate chelate buffered may offer a practical balance between elemental magnesium yield, bioavailability, and digestive comfort.
Learn more about the benefits of magnesium:
Why Magnesium is Still the Crown Jewel for Supporting Sleep
Magnesium Deficiency: How It Relates to Poor Mood and Mental Health
Is There a Link Between Magnesium Status and Healthy Cognition?
Magnesium L-Threonate: Champion of Cognitive Health
By Jesse Martin, M.S.